# Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation

> **NCT05468840** · PHASE3 · UNKNOWN · sponsor: **University of Ottawa** · enrollment: 20 (estimated)

## Conditions studied

- Suicidal Ideation

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT05468840
- **Lead sponsor:** University of Ottawa
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06
- **Primary completion:** 2023-12
- **Final completion:** 2024-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05468840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05468840, "Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05468840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*